-- Robert Preidt
MONDAY, July 8 (HealthDay News) -- Black Americans with blood
cancer do not live as long as white patients with the disease, a
new study finds, even when they receive equal levels of care.
Researchers looked at 84 black patients and more than 1,500
non-black patients with chronic lymphocytic leukemia (CLL), which
is a rare disease in blacks. All patients received the same
The time from diagnosis to referral for treatment was shorter
for blacks than whites, but blacks were more likely to have more
advanced CLL at the time of referral. Blacks responded as well as
whites to first-line treatment, but their cancer progressed more
rapidly, and their survival time was shorter.
This shorter survival time among blacks persisted even after the
researchers grouped patients according to factors related to the
severity of their disease, according to the study, which was
published online July 8 in the journal
The findings indicate that biological factors may account for
racial differences in survival among patients with CLL, the
researchers from the University of Texas M.D. Anderson Cancer
Center in Houston and Duke University Medical Center in Durham,
N.C., said in a journal news release.
For reasons that are unclear, minorities tend to have worse
cancer outcomes than whites. In black patients, poverty and limited
access to high-quality care often play a role, but some experts
believe that certain cancers can be more aggressive in minority
The American Cancer Society has more about
chronic lymphocytic leukemia.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.